There are now multiple forms of injectable PrEP medications. Lenacapavir, which is Gilead's injectable drug, differs from ...

Gilead Sciences (GILD) stock price has staged a strong comeback this year, helped by strong earnings and a recent $40 million ...

Twice-yearly lenacapavir was found to be superior to daily emtricitabine 200mg and tenofovir disoproxil fumarate 300mg.

The process for translating clinical trial results into action for young women in Africa has been left to our imaginations, ...

Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to ...

Gilead has several patent applications in India on lenacapavir. Two of these patent applications, filed in 2020, seek patents ...

It could be a real breakthrough for people at risk for HIV infection: A shot given every 6 months that reduces their risk by a whopping 96%.

In newly released data, lenacapavir, given via a twice-yearly injection, has shown remarkable effectiveness at eliminating ...

Season 4 of We're Here, which featured Sasha Velour, Jaida Essence Hall, Priyanka, and Latrice Royale, is now the final season of the drag-centric series on HBO and Max.

Very pleased to be hosting Gilead this afternoon, sorry. And we have joining us Dan O'Day, the company's Chairman and CEO; and Andy Dickinson, the company's CFO. Thank you both for taking time out ...

The optimism surrounding Gilead’s involvement in the PrEP market, particularly with the potential of lenacapavir, a drug that could significantly reduce infections and offer a twice-yearly ...